Dedicated to saving lives, CSL Behring is a global biotherapeutics leader that provides innovative therapies for the treatment of serious and rare conditions. The company strives to continually introduce innovations to enhance current treatments or to fill a medical need that is not currently being addressed. CSL Behring offers a work culture that encourages employee growth professionally and personally and helps its team achieve the professional careers they aspire to. This organization seeks passionate, collaborative, and innovative individuals to join its team. In the past, CSL Behring has supported work flexibility by hiring for temporary, part-time, and full-time, hybrid to 100% remote jobs, with some roles requiring travel.

As a specialty biotherapeutics company, CSL Behring develops protein-based wound-healing therapies, immunoglobulin therapies, fluid-replacement therapies, bleeding disorder therapies, hereditary angioedema therapies, and pulmonary therapies. The company is committed to serving communities of people living with serious conditions, such as von Willebrand disease, primary immunodeficiency, fibrinogen deficiency, hemophilia, hereditary Angioedema, genetic emphysema, and other rare diseases. CSL Behring is also a socially and environmentally friendly organization and is dedicated to minimizing its impact on the environment and conserving natural resources.

Dedicated to saving lives, CSL Behring is a global biotherapeutics leader that provides innovative therapies for the treatment of serious and rare conditions. The company strives to continually introduce innovations to enhance current treatments or to fill a medical need that is not currently being addressed. CSL Behring offers a work culture that encourages employee growth professionally and personally and helps its team achieve the professional careers they aspire to. This organization seeks passionate, collaborative, and innovative individuals to join its team. In the past, CSL Behring has supported work flexibility by hiring for temporary, part-time, and full-time, hybrid to 100% remote jobs, with some roles requiring travel.

As a specialty biotherapeutics company, CSL Behring develops protein-based wound-healing therapies, immunoglobulin therapies, fluid-replacement therapies, bleeding disorder therapies, hereditary angioedema therapies, and pulmonary therapies. The company is committed to serving communities of people living with serious conditions, such as von Willebrand disease, primary immunodeficiency, fibrinogen deficiency, hemophilia, hereditary Angioedema, genetic emphysema, and other rare diseases. CSL Behring is also a socially and environmentally friendly organization and is dedicated to minimizing its impact on the environment and conserving natural resources.